Cerenome, Inc. CNSY
0.79 USD -0.01 (-1.37%)
Nov 12, 2026, 3:17 PM EST
0.79 Day range 0.79
0.43 52-week range 19.00
- YTD
- -93.80%
- 1 year
- -94.36%
- Market cap
- 6.00M
- EPS (ttm)
- -3.36
- YTD return
- -93.80%
- 1-year return
- -94.36%
- Volume
- 308.18K
- Avg volume
- 649.16K
- Open
- 0.79
- Previous close
- 0.801
- Day's range
- 0.79 – 0.79
- 52-week range
- 0.43 – 19.00
5D +0.1536 (+23.22%)
Financials — quick view
CNSY Revenue — quarterly 411.00K
CNSY Net income — quarterly -9.01M
CNSY EPS — quarterly -1.31
News
Cerenome to Review REYOBIQ ReSPECT-LM Data Presented at SNO Conference and Provide CNSide Commercial Update on November 16 
Cerenome Appoints Director Ron Andrews as Chief Business Officer 
12 Health Care Stocks Moving In Wednesday's Intraday Session 
CNSide Diagnostics Inks National In-Network Laboratory Ancillary Provider With Aetna Health Plans - 12 Health Care Stocks Moving In Tuesday's Intraday Session
Cerenome To Report Poster Presentation Of Interim Data From Its Current ReSPECT-LMM Multidose Trial Of REYOBIQ At 31st Annual Meeting And Education Day - Cerenome Presents New Preclinical Data At 16th Biennial Rivkin Ovarian Cancer Research Symposium Regarding Immunomodulatory Properties Of REYOBIQ
- Lake Street Maintains Buy on Cerenome, Lowers Price Target to $31
- Cerenome Anticipates $1.55M In Payer Billings In Q3
ServiceNow To Rally More Than 18%? Here Are 10 Top Analyst Forecasts For Friday
Your note
Sign in to keep a note on CNSY — it syncs with the Stock Master app.